NEW YORK (GenomeWeb News) – Qiagen and Merck will collaborate to provide HPV screening and vaccination to women in the developing world as part of the Clinton Global Initiative, the partners said today.

The goal is to integrate their offerings and provide them for free in order to combat cervical cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.